Recurrent Ovarian Cancer Online

Progression-free Survival

A tool for researcher and health care professionals to prognosticate progression-free survival decisions in patients with recurrent ovarian cancer treated with platinum-based chemotherapy.

Note that our website is currently experiencing compatibility issues with Windows 8 operating system and also with Internet Explorer 10. If you are using both or either of these, please click here for instructions on how to enable the compatibility view settings to overcome these issues. Alternatively, if available please use Internet Explorer 7, 8, or 9.

Your Patient Characteristics at Disease Relapse

Largest Tumour size
Last platinum chemotherapy (months)
CA-125 (IU/mL)
Number of organ sites of metastasis
White blood cell (x 10⁹/L)

ROC Online

Disclaimer

The NHMRC clinical Trials Centre strives to keep information stored in the ROC Online tool up to date, but does not guarantee the accuracy, reliability or currency of the information. Any errors in the information that are brought to our attention will be corrected as soon as possible. The CTC reserves the right to change at any time without notice any information stored in the ROC Online tool.

The CTC may provide links to a number of external websites via this website. Monitoring and reviewing content of these third party external websites is not the responsibility of the CTC nor does the CTC endorse, approve or recommend the content, owners or operators of websites and applications available through this website.

The CTC accepts no liability for any loss or damage a person suffers because that person has directly or indirectly relied on any information stored on this server.

Privacy

The University of Sydney is subject to the NSW Privacy and Personal Information Protection Act 1998 (the Act). The University's Privacy Management Plan produced in accordance with section 33 of the Act contains the University's Privacy Policy (pdf) and how it will be translated into the University's business practices.